Adding a dedicated pediatric infusion center for biologic drug treatments will further a 20-year history of providing high-quality care for kids.
INFUSION OF
FUNDS
$2.5 MILLION GIFT FROM BRISTOL MYERS SQUIBB FOUNDATION TO SUPPORT BIOLOGIC THERAPIES FOR CHILDREN.
T
he Bristol-Myers Squibb Children’s Hospital (BMSCH) at Robert Wood Johnson University Hospital has received a $2.5 million commitment from the Bristol Myers Squibb Foundation in honor of the hospital’s 20th anniversary of caring for the children of New Jersey. The gift will support a dedicated pediatric infusion center to provide a
child-appropriate site for outpatient biologic drug treatments. Such treatments are becoming the standard of care in gastroenterology, rheumatology, genetics, neurology, nephrology and other specialties. “The need for a pediatric infusion center will only expand over the coming years, and this generous gift will place us at the forefront in treatment
modalities,” says William Faverzani, Vice President and Chief Administrative Officer at BMSCH. “We are so grateful that the Bristol Myers Squibb Foundation continues to support our mission to improve children’s health as we enter our third decade, as they have for the past 20 years.” The addition of a pediatric infusion center will provide family-centered care to children requiring short- or long-term infusion therapy, therapeutic injections, sedation or provocative stimulation testing. Infusion therapy will be administered to infants, children and adolescents who require either onetime or ongoing IV therapy for a variety of acute and chronic illnesses including gastrointestinal, rheumatologic, immune, genetic, neurologic, renal, endocrine and blood disorders. With a dedicated center in close proximity to the Pediatric Intensive Care Unit, patients receiving infusions will have highly skilled and personalized care with the convenience of an outpatient setting. “We are proud to support the pediatric infusion center as part of our long-term commitment to The Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital,” says John Damonti, President of the Bristol Myers Squibb Foundation. “In line with our priority to facilitate access to high-quality care for every patient, we recognize the need for a child-appropriate facility and are delighted to help the hospital realize its vision.” “The RWJ University Hospital Foundation’s 20-year partnership with the Bristol Myers Squibb Foundation has allowed our facility to provide lifechanging services to pediatric patients throughout the region,” says Mary Burke, Vice President, RWJ University Hospital Foundation. “We look forward to continuing to work together on improving the experience and providing spaces for our pediatric patients to heal.”
To learn more about the comprehensive care provided at The Bristol-Myers Squibb Children’s Hospital at RWJUH, please visit www.rwjbh.org/bmsch.
Robert Wood Johnson University Hospital
RWJUHNB_20thPediatricPractice_Sum21_Final.indd 21
|
RWJBH.ORG/NEWBRUNSWICK
| 21
6/2/21 4:44 PM
